
This scholarly article from Aesthetic Surgery Journal Open Forum discusses the phenomenon of “Ozempic Face,” a term used to describe the accelerated facial aging and volume loss experienced by some patients undergoing rapid weight loss from GLP-1 receptor agonists like Ozempic. The authors, plastic surgery residents and a practicing plastic surgeon, present a systematic review of existing literature on these medications within plastic surgery and analyze public perception using Google Trends. The study highlights the benefits and potential adverse effects of GLP-1 receptor agonists, particularly their gastrointestinal side effects and impact on facial morphology, offering surgical and non-surgical solutions for the aesthetic changes. Ultimately, it aims to educate the plastic surgery community on managing this emerging patient population and emphasizes the need for clear clinical guidelines and further research into the long-term effects.
Audio Overview (Google NotebookLM)
(14 minutes 29 seconds)
